$KZR.US – ranked positive on March 23rd, 2022

$KZR.US – ranked positive on March 23rd, 2022

Kezar Life Sciences – (KZR, +N, 23-Mar-22)

Franklin Berger (Non-Executive since 2016) purchased $1.3 million of stock at $16.25 on March 21st, increasing his holding by 10%. This is his first open-market purchase and its size is larger than his two previous subscriptions combined in February and June 2020 at $2.60 and $5.50 respectively.

He has a very good record in Essa Pharma Inc, another pharmaceutical company where he is a director, and made an equally large purchase in August 2020 which was extremely well-timed. The stock has more than doubled over a year and this is interesting to see him making this large purchase.

We are ranking the stock +N.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.

If you are interested in our Stocks of the Week
those services may also be useful for you

Desktop
Service

Timely data delivery customised to every user, backed by analysis tools on our internal website

Signals
Data

We rank the stocks where transactions are most likely to indicate future share price performance

Shares
Buybacks

Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top